uniQure
QURE
$4.95
Share price
5.77%
Change (1 day)
-75.97%
Change (1 year)
Earnings for uniQure (QURE)
Earnings in 2023 (TTM): -$0.31 B
According to uniQure's latest financial reports the company's current earnings (TTM) are -$0.3 B. In 2022 the company made an earning of -$0.13 B a decrease over its 2021 earnings that were of $0.33 B.The earnings displayed on this page is the company's Pretax Income.
Earnings history for uniQure from 2013 to 2023
Annual earnings
| Year | Earnings | Change |
|---|---|---|
2023 (TTM)  | -$0.31 B | 139.01% |
| 2022 | -$0.13 B | -138.54% |
| 2021 | $0.33 B | -335.29% |
| 2020 | -$0.15 B | 13.88% |
| 2019 | -$0.13 B | 49.51% |
| 2018 | -$83.08 M | 4.55% |
| 2017 | -$79.46 M | 12.65% |
| 2016 | -$70.54 M | -9.59% |
| 2015 | -$78.02 M | 66.95% |
| 2014 | -$46.74 M | 30.8% |
| 2013 | -$35.73 M |
Earnings for similar companies or competitors
| Company | Earnings | Earnings differencediff. | Country |
|---|---|---|---|
 Amgen AMGN | $4.34 B | -1,582.51% | 🇺🇸 USA |
 Sanofi SNY | $7.26 B | -2,577.37% | 🇫🇷 France |
 Sangamo Therapeutics
SGMO | -$0.25 B | -17.17% | 🇺🇸 USA |
 bluebird bio
BLUE | -$91.14 M | -68.90% | 🇺🇸 USA |
 BioMarin Pharmaceutical BMRN | $0.23 B | -180.98% | 🇺🇸 USA |
 Avidity Biosciences RNA | -$0.23 B | -21.97% | 🇺🇸 USA |